E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Rutgers Cancer Institute, New Brunswick, New Jersey RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey Last updated February 2026